Basit öğe kaydını göster

dc.contributor.authorSahin, Hayrettin
dc.date.accessioned2020-11-20T16:22:09Z
dc.date.available2020-11-20T16:22:09Z
dc.date.issued2012
dc.identifier.issn2147-2270
dc.identifier.urihttps://hdl.handle.net/20.500.12809/4116
dc.descriptionWOS: 000219391200005en_US
dc.description.abstractAim: Patients who have a persistently elevated or a rising PSA level following a prior negative biopsy can be a stressful situation for both the urologist and the patient. We reviewed indications of repeat biopsy. Findings: The indications for a repeat biopsy are rising and/or persistent PSA, suspicious digital rectal examination (DRE), atypical small aciner proliferation (ASAP) in biopsy and extensive high grade prostatic intraepithelial neoplasia (HGPIN) in biopsy. Result: Repeat biopsies should include a minimum of 14 cores, the 12 cores recommended for an initial biopsy and 2 additional cores obtained form the right and left anterior apex. Saturation biopsy must be performed in patients with persistently elevated PSA despite multiple negative prior biopsies. Repeat biopsy can be performed 6 weeks later with no significant difference in morbidity.en_US
dc.item-language.isoturen_US
dc.publisherGalenos Yayinciliken_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectProstate Canceren_US
dc.subjectRepeat Biopsyen_US
dc.subjectPSAen_US
dc.subjectIndicationen_US
dc.titleRepeat prostate biopsy: who, when, how?en_US
dc.item-typereviewen_US
dc.contributor.departmenten_US
dc.contributor.departmentTemp[Sahin, Hayrettin] Mugla Univ, Tip Fak, Urol Anabilim Dali, Mugla, Turkeyen_US
dc.identifier.volume11en_US
dc.identifier.issue2en_US
dc.identifier.startpage103en_US
dc.identifier.endpage107en_US
dc.relation.journalUroonkoloji Bulteni-Bulletin of Urooncologyen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster